| Cash Flow | 2025-09-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Net earnings | 82 | 488 | 297 | 103 |
| Depreciation and amortization | 56 | 162 | 107 | 54 |
| Stock-based compensation | 10 | 64 | 40 | 13 |
| Deferred income taxes | 84 | -16 | -19 | -1 |
| Loss on divestiture | 0 | -112 | -112 | -112 |
| Pension settlement charge | - | 0 | 0 | - |
| Other | 12 | 9 | -5 | 5 |
| Receivables, net | -118 | -71 | -64 | -84 |
| Inventories, net | 55 | 54 | 12 | 6 |
| Prepaid expenses and other current assets | 41 | 28 | 39 | 38 |
| Accounts payable and accrued liabilities | -40 | -87 | -138 | -137 |
| Operating lease right-of-use assets and liabilities, net | -2 | 1 | - | 0 |
| Income taxes payable / prepaid | -107 | -17 | -16 | 42 |
| Net cash provided by operations | 93 | 687 | 401 | 221 |
| Capital expenditures | 36 | 145 | 92 | 39 |
| Proceeds from divestiture, net of cash divested | 0 | 128 | 128 | 128 |
| Other | -2 | 1 | 1 | 0 |
| Net cash (used for) provided by investing activities | -34 | -18 | 35 | 89 |
| Notes and loans payable, net | 214 | 50 | 184 | 0 |
| Treasury stock purchased | 129 | 257 | 257 | 107 |
| Cash dividends paid to clorox stockholders | 151 | 452 | 302 | 151 |
| Cash dividends paid to noncontrolling interests | - | 16 | - | - |
| Issuance of common stock for employee stock plans and other | 7 | 30 | 29 | 21 |
| Net cash used for financing activities | -59 | -645 | -346 | -237 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1 | -2 | -3 | 2 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -1 | 22 | 87 | 75 |
| Cash and cash equivalents at beginning of period | 170 | 207 | 207 | 207 |
| Cash and cash equivalents at end of period | 169 | 229 | 294 | 282 |
CLOROX CO DE (CLX)
CLOROX CO DE (CLX)